NDC 58468-4663

Cerezyme 40 U per 1 mL injection, powder, lyophilized, for solution

On the label: Genzyme Corporation.

United States: 2Ireland: 1Italy: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Genzyme CorporationFramingham, MA, United StatesMakes it, makes the active ingredient and tests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme CorporationFramingham, MA, United StatesMakes it, makes the active ingredient and tests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme Ireland LimitedWaterford, IrelandMakes it, tests it, packages it and labels it Problems found, fixed voluntarilyFeb 25, 2022 · 7 inspections
Sanofi S.r.l.Anagni, ItalyMakes it, tests it, packages it and labels it Problems found, fixed voluntarilyOct 29, 2024 · 7 inspections
Charles River Laboratories, Inc.Malvern, PA, United StatesTests it No problems foundJan 20, 2026 · 6 inspections
Eurofins Biopharma Product Testing Ireland LimitedIrelandTests it Problems found, fixed voluntarilyMay 26, 2023 · 5 inspections
Genzyme CorporationNorthborough, MA, United StatesPackages it and labels it No problems foundAug 14, 2025 · 6 inspections
Genzyme CorporationFramingham, MA, United StatesTests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action

Product details

Generic drug
Imiglucerase: every company that makes it
Form
injection, powder, lyophilized, for solution, intravenous
Strength
40 U per 1 mL
Approval
BLA BLA020367
On the market since
May 23, 1994
Package NDCs
58468-4663-1
Official label
DailyMed (National Library of Medicine), updated Aug 27, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?